AI
DVAX

Atom Investors’s Dynavax Technologies DVAX Stock Holding History

Atom Investors’s Portfolio DVAX Stock Details DVAX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-14,326
Closed -$161K – 502
2024
Q2 		$161K Buy
+14,326
New +$167K 0.02% 433
2022
Q3 		– Sell
-26,326
Closed -$331K – 314
2022
Q2 		$331K Buy
+26,326
New +$280K 0.14% 143

Other funds holding DVAX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.62B AUM 138.67% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
CC
Chicago Capital Chicago, Illinois $4.15B AUM 31.09% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Atom Investors's DVAX Position: Q3 2024 in Review

Atom Investors sold out of Dynavax Technologies (DVAX) in Q3 2024, closing a stake of 14,326 shares — an estimated $161K sold.

Atom Investors first reported a position in DVAX in Q2 2022 and held it in 2 quarters. The position peaked at $331K in Q2 2022. 251 funds tracked by Wall St. Rank hold DVAX as of Q3 2024.

  • Atom Investors reported no remaining Dynavax Technologies position as of Q3 2024 after selling out during the quarter.
  • Atom Investors sold 14,326 Dynavax Technologies shares in Q3 2024, an estimated $161K.
  • Atom Investors first reported a position in Dynavax Technologies in Q2 2022 and held it in 2 quarters.
  • Atom Investors's Dynavax Technologies position peaked at $331K in Q2 2022.
  • 251 funds tracked by Wall St. Rank held Dynavax Technologies as of Q3 2024.

Based on Atom Investors's 13F filing for Q3 2024, filed 14 Nov 2024.